Abbott Labs develops an absorbable stent

As reported in the Wall Street Journal Abbott Labs has developed a coronary artery stent that is reabsorbded into the vessel once it is no longer needed. The intent is to return that vessel to its normal state and potentially reducing the risk of blood clots.